Nonprofits›Wittek Research Foundation For Hypertrophic Cardiomyopathy Inc
Medical Research
Wittek Research Foundation For Hypertrophic Cardiomyopathy Inc
TENAFLY, NJ
Total revenue
$74K
Total expenses
$41K
Net assets
$71K
Grants received
$60K
2 grants
EIN
861682122
Tax year
2023
Mission
Dedicated to supporting research that will transform the prevention, diagnosis, and treatment of hypertrophic cardiomyopathy.
Financials
FY 2023
Revenue
Contributions & grants$74K
Program service revenue—
Investment income—
Other revenue—
Total revenue$74K
Expenses
Grants paid—
Salaries & benefits—
Fundraising—
Other expenses$7K
Total expenses$41K
Total assets$71K
Net assets$71K
People
3 listed
NameRoleCompensation
PAMELA COHEN MD
PRESIDENT AND FOUNDER
Board
—
20 hrs/wk
SAM BLUMENSTYK JD
TREASURER
Board
—
2 hrs/wk
PAMELA GOLDSTEIN JD
SECRETARY
Board
—
2 hrs/wk
Grants received
Showing 2 of 2
FromAmountPurposeYear
Funded by
$60K from 1 funder · 2 grants · 2022–2023
Morgan Stanley Global Impact Funding Trust Inc
$60K · 2 grants · 2022–2023
Details
EIN861682122
NTEE codeH43
Subsection03
Ruling date2021-07